Oramed Appoints Yadin Rozov to its Board of Directors
NEW YORK , April 4, 2022 /PRNewswire/ – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the appointment of Yadin Rozov to its Board of Directors effective April 1, 2022 .
